MARKET

HAE

HAE

Haemonetics Corp Mass
NYSE
54.04
-1.48
-2.67%
After Hours: 54.29 +0.25 +0.46% 16:55 03/27 EDT
OPEN
55.28
PREV CLOSE
55.52
HIGH
55.54
LOW
53.88
VOLUME
1.65M
TURNOVER
--
52 WEEK HIGH
87.32
52 WEEK LOW
47.32
MARKET CAP
2.51B
P/E (TTM)
14.85
1D
5D
1M
3M
1Y
5Y
1D
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness
Simply Wall St · 3d ago
Haemonetics Becomes Oversold (HAE)
NASDAQ · 4d ago
Weekly Report: what happened at HAE last week (0316-0320)?
Weekly Report · 6d ago
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year
The Motley Fool · 03/20 22:03
Weekly Report: what happened at HAE last week (0309-0313)?
Weekly Report · 03/16 09:44
Is Haemonetics (HAE) Quietly Rewiring Its Margin Profile Through NexSys PCS And Hospital Acquisitions?
Simply Wall St · 03/15 16:12
Haemonetics Expands Hospital Portfolio As Investors Weigh Growth And Valuation
Simply Wall St · 03/14 07:36
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness
Simply Wall St · 03/12 22:36
More
About HAE
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.

Webull offers Haemonetics Corp stock information, including NYSE: HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.